Marking a milestone in surgery, the first bilateral robotic nipple-sparing mastectomy has been performed in New York City, after the procedure was given US Food and Drug Administration (FDA) clearance earlier this year.
The procedure – using Intuitive Surgical’s da Vinci Single-Port (SP) robotic system – on a 44-year-old patient with a BRCA1 genetic mutation was done by Tristen Park, MD, a breast surgical oncologist and Associate Professor of Surgery at the Icahn School of Medicine at Mount Sinai, with Alice Yao, MD, Associate Professor of Surgery (Plastic and Reconstructive Surgery), performing immediate implant-based breast reconstruction.
The patient recovered well and returned home the day after surgery.
The robotic system enables surgeons to remove breast tissue through a 3.5-cm incision below the armpit while preserving the breast skin and nipple-areolar complex. The incision is away from the breast itself. Combined with immediate reconstruction, this approach aims to preserve the breast’s external appearance without traditional mastectomy incisions.
“The successful completion of this procedure is an exciting milestone for Mount Sinai and reflects the extraordinary dedication and collaboration of our surgical teams,” said Elisa Port, MD, Chief of Breast Surgery at Mount Sinai and the Director of the Dubin Breast Centre at The Mount Sinai Hospital.
Nipple-sparing mastectomy may be an option for selected patients undergoing surgery for breast cancer or to reduce their risk of developing it.
For those with BRCA1 or BRCA2 mutations, preventive mastectomy can significantly reduce breast cancer risk. Preserving the nipple and breast skin may also support body image and emotional well-being after surgery.
“Robotic-assisted nipple-sparing mastectomy can offer substantially improved precision and visualisation for the surgeon. Published data thus far have demonstrated promising outcomes in preserving sensation, as well as patient satisfaction and quality-of-life measures compared with traditional approaches,” said Park.
Park began exploring robotic breast surgery in 2022 when she travelled to South Korea as a visiting professor and observed Professor Han-Byoel Lee, MD, PhD, and his team perform robotic breast surgery at Seoul National University. She subsequently pursued mentorship and training with robotic breast surgeons in France, South Korea, Taiwan, and the United States.
She was one of the first breast surgeons credentialed to perform this procedure with this robotic system in the United States and the first in New York City. She also serves on the American Society of Breast Surgeons’ Robotic Surgery Task Force, which is working to develop national guidelines and best practices, establish a nationwide robotic breast surgery registry, and advance surgeon education.
See more from MedicalBrief archives:
Double mastectomy no guarantee against cancer – Canadian cohort study
Global breast cancer cases expected to rise to 3.5m by 2050 – Lancet
Anxiety an important factor in mastectomy choices
